Palo Alto, Calif. — Coapt Systems Inc., based here, recently announced its launch of FDA-approved Hydrelle, a hyaluronic acid-based filler for treating facial wrinkles such as nasolabial folds, reports PRNewswire.
According to the company, Hydrelle is formulated with the anesthetic lidocaine for greater patient comfort. The company calls Hydrelle “a financially attractive alternative to traditional fillers such as Juvéderm by Allergan Medical and Restylane by Medicis Pharmaceutical.” The company adds that Hydrelle use requires approximately half the typical injection volumes of other fillers, thus requiring fewer syringes to correct facial wrinkles.
In a randomized, controlled US study of 208 patients, Hydrelle was shown to be safe and effective, the company says, adding that in a multicenter, international study, Hydrelle demonstrated patient/physician satisfaction and filler effectiveness for up to one year.
